Topiramate
Product Images NDC 61919-185

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 61919-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure01)

A Kaplan-Meier curve depicting the cumulative rates for time to first seizure in patients taking Topiramate at two doses: 50 mg/day and 400 mg/day. The x-axis represents time in days, and the y-axis shows cumulative seizure rates, highlighting a significant difference between dosage groups over time.*

FDA Label Image

Image Description (Label)

Packaging label for TOPIRAMATE 100 mg tablets, containing 30 tablets per bottle. The label indicates it is a generic for TOPAMAX, each tablet containing 100 mg of topiramate USP. The product is labeled by DIRECT RX, located in Alpharetta, GA. The label includes a warning that the medication may cause drowsiness or dizziness and advises caution.*

FDA Label Image

Image Description (Module)

Chemical structure of topiramate showing its molecular arrangement with labeled functional groups, including methyl groups, oxygen atoms, and a sulfamate group. The diagram illustrates the compound's stereochemistry with wedge and dash bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.